Reaction
Burkholderia Cepacia Complex Infection reporting signals
As of the last recalculation, Burkholderia Cepacia Complex Infection appears in 286 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is CHLORHEXIDINE GLUCONATE (PRR 143.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Chlorhexidine Gluconate | 17 | 143.9 | 144.2 |
| Atovaquone | 8 | 74.4 | 74.4 |
| Lumacaftor And Ivacaftor | 8 | 69.9 | 69.9 |
| Ganciclovir | 9 | 66.0 | 66.1 |
| Anti-Thymocyte Globulin (Rabbit) | 7 | 64.7 | 64.8 |
| Ganciclovir Sodium | 9 | 63.9 | 63.9 |
| Tobramycin | 18 | 58.1 | 58.1 |
| Tobramycin Solution | 9 | 56.3 | 56.3 |
| Tobramycin Sulfate | 9 | 54.6 | 54.6 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 7 | 41.8 | 41.9 |
| Dornase Alfa | 10 | 38.4 | 38.4 |
| Ivacaftor | 3 | 27.8 | 27.8 |
| Remdesivir | 4 | 22.1 | 22.1 |